243 related articles for article (PubMed ID: 23871852)
1. Improvements in hip trabecular, subcortical, and cortical density and mass in postmenopausal women with osteoporosis treated with denosumab.
Genant HK; Libanati C; Engelke K; Zanchetta JR; Høiseth A; Yuen CK; Stonkus S; Bolognese MA; Franek E; Fuerst T; Radcliffe HS; McClung MR
Bone; 2013 Oct; 56(2):482-8. PubMed ID: 23871852
[TBL] [Abstract][Full Text] [Related]
2. Denosumab densitometric changes assessed by quantitative computed tomography at the spine and hip in postmenopausal women with osteoporosis.
McClung MR; Zanchetta JR; Høiseth A; Kendler DL; Yuen CK; Brown JP; Stonkus S; Goemaere S; Recknor C; Woodson GC; Bolognese MA; Franek E; Brandi ML; Wang A; Libanati C
J Clin Densitom; 2013; 16(2):250-6. PubMed ID: 22572531
[TBL] [Abstract][Full Text] [Related]
3. Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density.
Genant HK; Engelke K; Hanley DA; Brown JP; Omizo M; Bone HG; Kivitz AJ; Fuerst T; Wang H; Austin M; Libanati C
Bone; 2010 Jul; 47(1):131-9. PubMed ID: 20399288
[TBL] [Abstract][Full Text] [Related]
4. Odanacatib treatment affects trabecular and cortical bone in the femur of postmenopausal women: results of a two-year placebo-controlled trial.
Engelke K; Fuerst T; Dardzinski B; Kornak J; Ather S; Genant HK; de Papp A
J Bone Miner Res; 2015 Jan; 30(1):30-8. PubMed ID: 24898537
[TBL] [Abstract][Full Text] [Related]
5. Regional distribution of spine and hip QCT BMD responses after one year of once-monthly ibandronate in postmenopausal osteoporosis.
Engelke K; Fuerst T; Dasic G; Davies RY; Genant HK
Bone; 2010 Jun; 46(6):1626-32. PubMed ID: 20226286
[TBL] [Abstract][Full Text] [Related]
6. 3D-modeling from hip DXA shows improved bone structure with romosozumab followed by denosumab or alendronate.
Lewiecki EM; Betah D; Humbert L; Libanati C; Oates M; Shi Y; Winzenrieth R; Ferrari S; Omura F
J Bone Miner Res; 2024 May; 39(4):473-483. PubMed ID: 38477808
[TBL] [Abstract][Full Text] [Related]
7. Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture.
Simon JA; Recknor C; Moffett AH; Adachi JD; Franek E; Lewiecki EM; McClung MR; Mautalen CA; Ragi-Eis S; Nicholson GC; Muschitz C; Nuti R; Törring O; Wang A; Libanati C
Menopause; 2013 Feb; 20(2):130-7. PubMed ID: 23010883
[TBL] [Abstract][Full Text] [Related]
8. Femoral and vertebral strength improvements in postmenopausal women with osteoporosis treated with denosumab.
Keaveny TM; McClung MR; Genant HK; Zanchetta JR; Kendler D; Brown JP; Goemaere S; Recknor C; Brandi ML; Eastell R; Kopperdahl DL; Engelke K; Fuerst T; Radcliffe HS; Libanati C
J Bone Miner Res; 2014 Jan; 29(1):158-65. PubMed ID: 23794225
[TBL] [Abstract][Full Text] [Related]
9. Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial.
Brown JP; Engelke K; Keaveny TM; Chines A; Chapurlat R; Foldes AJ; Nogues X; Civitelli R; De Villiers T; Massari F; Zerbini CAF; Wang Z; Oates MK; Recknor C; Libanati C
J Bone Miner Res; 2021 Nov; 36(11):2139-2152. PubMed ID: 34190361
[TBL] [Abstract][Full Text] [Related]
10. Denosumab significantly increases DXA BMD at both trabecular and cortical sites: results from the FREEDOM study.
Bolognese MA; Teglbjærg CS; Zanchetta JR; Lippuner K; McClung MR; Brandi ML; Høiseth A; Lakatos P; Moffett AH; Lorenc RS; Wang A; Libanati C
J Clin Densitom; 2013; 16(2):147-53. PubMed ID: 22521543
[TBL] [Abstract][Full Text] [Related]
11. Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass.
Genant HK; Engelke K; Bolognese MA; Mautalen C; Brown JP; Recknor C; Goemaere S; Fuerst T; Yang YC; Grauer A; Libanati C
J Bone Miner Res; 2017 Jan; 32(1):181-187. PubMed ID: 27487526
[TBL] [Abstract][Full Text] [Related]
12. Inverse Correlation at the Hip Between Areal Bone Mineral Density Measured by Dual-Energy X-ray Absorptiometry and Cortical Volumetric Bone Mineral Density Measured by Quantitative Computed Tomography.
Amstrup AK; Jakobsen NF; Lomholt S; Sikjaer T; Mosekilde L; Rejnmark L
J Clin Densitom; 2016; 19(2):226-33. PubMed ID: 25700661
[TBL] [Abstract][Full Text] [Related]
13. Spine Volumetric BMD and Strength in Premenopausal Idiopathic Osteoporosis: Effect of Teriparatide Followed by Denosumab.
Agarwal S; Shane E; Lang T; Shiau S; Kamanda-Kosseh M; Bucovsky M; Lappe JM; Stubby J; Recker RR; Hu Y; Wang Z; Edward Guo X; Cohen A
J Clin Endocrinol Metab; 2022 Jun; 107(7):e2690-e2701. PubMed ID: 35428889
[TBL] [Abstract][Full Text] [Related]
14. Effects of odanacatib on the radius and tibia of postmenopausal women: improvements in bone geometry, microarchitecture, and estimated bone strength.
Cheung AM; Majumdar S; Brixen K; Chapurlat R; Fuerst T; Engelke K; Dardzinski B; Cabal A; Verbruggen N; Ather S; Rosenberg E; de Papp AE
J Bone Miner Res; 2014 Aug; 29(8):1786-94. PubMed ID: 24643905
[TBL] [Abstract][Full Text] [Related]
15. Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study.
Roux C; Hofbauer LC; Ho PR; Wark JD; Zillikens MC; Fahrleitner-Pammer A; Hawkins F; Micaelo M; Minisola S; Papaioannou N; Stone M; Ferreira I; Siddhanti S; Wagman RB; Brown JP
Bone; 2014 Jan; 58():48-54. PubMed ID: 24141036
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional structural analysis of the proximal femur in an age-stratified sample of women.
Nicks KM; Amin S; Melton LJ; Atkinson EJ; McCready LK; Riggs BL; Engelke K; Khosla S
Bone; 2013 Jul; 55(1):179-88. PubMed ID: 23486182
[TBL] [Abstract][Full Text] [Related]
17. Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study).
Tsai JN; Uihlein AV; Burnett-Bowie SM; Neer RM; Derrico NP; Lee H; Bouxsein ML; Leder BZ
J Clin Endocrinol Metab; 2016 May; 101(5):2023-30. PubMed ID: 26964731
[TBL] [Abstract][Full Text] [Related]
18. Distribution of bone density and cortical thickness in the proximal femur and their association with hip fracture in postmenopausal women: a quantitative computed tomography study.
Yang L; Udall WJ; McCloskey EV; Eastell R
Osteoporos Int; 2014 Jan; 25(1):251-63. PubMed ID: 23719860
[TBL] [Abstract][Full Text] [Related]
19. Denosumab Reduces Cortical Porosity of the Proximal Femoral Shaft in Postmenopausal Women With Osteoporosis.
Zebaze R; Libanati C; McClung MR; Zanchetta JR; Kendler DL; Høiseth A; Wang A; Ghasem-Zadeh A; Seeman E
J Bone Miner Res; 2016 Oct; 31(10):1827-1834. PubMed ID: 27082709
[TBL] [Abstract][Full Text] [Related]
20. Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial.
Brixen K; Chapurlat R; Cheung AM; Keaveny TM; Fuerst T; Engelke K; Recker R; Dardzinski B; Verbruggen N; Ather S; Rosenberg E; de Papp AE
J Clin Endocrinol Metab; 2013 Feb; 98(2):571-80. PubMed ID: 23337728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
